Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
297 hedge funds and large institutions have $4.54B invested in Abiomed Inc in 2016 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 99 increasing their positions, 108 reducing their positions, and 31 closing their positions.
87% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 31
59% more call options, than puts
Call options by funds: $11.8M | Put options by funds: $7.39M
15% more capital invested
Capital invested by funds: $3.94B → $4.54B (+$602M)
8% more funds holding
Funds holding: 274 → 297 (+23)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
8% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 108
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$43.2M |
| 2 |
Renaissance Technologies
New York
|
+$33.3M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$32.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.8M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$53.7M |
| 2 |
Primecap Management
Pasadena,
California
|
-$52.6M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$47.9M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$25.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$23.2M |
ABMD Hedge Fund Activity: Q2 2016 in Review
297 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2016, worth a combined $4.54B — up 15% from $3.94B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new ABMD positions and 31 closed out — a net gain of 27 holders — while 99 added to existing stakes and 108 trimmed.
The largest buyer was Macquarie Group, adding an estimated $43.2M. The largest seller was BlackRock Fund Advisors, cutting an estimated $53.7M.
- 297 institutional investors held Abiomed Inc (ABMD) as of Q2 2016, up from 274 in Q1 2016.
- Funds reported $4.54B of Abiomed Inc stock for Q2 2016, up 15% quarter-over-quarter.
- 58 funds opened new Abiomed Inc positions in Q2 2016 and 31 closed out, a net change of +27 holders.
- The largest Abiomed Inc buyer in Q2 2016 was Macquarie Group, an estimated $43.2M added.
- The largest Abiomed Inc seller in Q2 2016 was BlackRock Fund Advisors, an estimated $53.7M sold.
Based on aggregated 13F filings for Q2 2016.